WebbChristian Récher, Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Université Toulouse III Paul … WebbChristian Recher spends much of his time researching Myeloid leukemia, Internal medicine, Oncology, Cancer research and Cytarabine. His Myeloid leukemia study combines topics …
ORCID
Webb25 mars 2024 · Anne-Charlotte De Grande 4, Christian Récher 1,2,3,z and Arnaud Pigneux 4,5,6,z 1 Service d’Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059 Toulouse, France; [email protected] (S.T.); WebbChristian Récher, Corresponding Author Christian Récher [email protected] orcid.org/0000-0002-3332-4525 Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France Université Toulouse III Paul Sabatier, Toulouse, France security tsar
Molecular classification and prognosis in younger adults with …
Webb20 sep. 2011 · Hématologie secteur 2. 05-31-15-63-09. Greffes de cellules souches hématopoïétiques. 05-31-15-62-46. Hospitalisations de jour. Téléphone. Infirmière de programmation. 05-31-15-63-02. Assistance aux malades ambulatoires (AMA) Webb6 maj 2024 · cancers Article CD34+CD38 CD123+ Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents François Vergez 1,2,3,* , Marie-Laure Nicolau-Travers 1,3, Sarah Bertoli 2,3,4, Jean-Baptiste Rieu 1, Suzanne Tavitian 4, Pierre Bories 5, Isabelle … Webb24 juli 2024 · z Arnaud Pigneux and Christian Récher are joint last author. Received: 8 June 2024; Accepted: 22 July 2024; Published: 24 July 2024 Abstract: Two recent phase 3 trials showed that outcomes for relapsed/refractory (R/R) FLT3-mutated acute myeloid leukemia (AML) patients may be improved by a single-agent tyrosine kinase inhibitor security trustee vs collateral agent